HRT Financial’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

HRT Financial’s Portfolio MTACU Stock Details MTACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-43,415	Closed	-$431K	–	3481
2022 Q3	$431K	Hold	43,415	–	–	﹤0.01%	1748
2022 Q2	$418K	Hold	43,415	–	–	﹤0.01%	1798
2022 Q1	$425K	Hold	43,415	–	–	﹤0.01%	1966
2021 Q4	$435K	Hold	43,415	–	–	﹤0.01%	2000
2021 Q3	$442K	Hold	43,415	–	–	﹤0.01%	2110
2021 Q2	$435K	Hold	43,415	–	–	﹤0.01%	1899
2021 Q1	$436K	Hold	43,415	–	–	﹤0.01%	1884
2020 Q4	$455K	Buy	+43,415	New	+$453K	0.01%	1073

Other funds holding MTACU

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

HRT Financial's MTACU Position: Q4 2022 in Review

HRT Financial sold out of MedTech Acquisition Corporation Unit (MTACU) in Q4 2022, closing a stake of 43,415 shares — an estimated $431K sold.

HRT Financial first reported a position in MTACU in Q4 2020 and held it in 8 quarters. The position peaked at $455K in Q4 2020. 4 funds tracked by Wall St. Rank hold MTACU as of Q4 2022.

HRT Financial reported no remaining MedTech Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
HRT Financial sold 43,415 MedTech Acquisition Corporation Unit shares in Q4 2022, an estimated $431K.
HRT Financial first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 8 quarters.
HRT Financial's MedTech Acquisition Corporation Unit position peaked at $455K in Q4 2020.
4 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.